Vesugen

Also known as: Vascular Peptide, Lys-Glu-Asp, KED Peptide

Cardiovascular

Preclinical

Vesugen is a short tripeptide bioregulator developed for vascular health and cardiovascular support. Part of the Russian Khavinson peptide series, it is designed to support endothelial function, reduce arterial stiffness, and promote vascular tissue regeneration. Used in anti-aging and longevity protocols alongside other bioregulator peptides.

Regulatory & Approval Status

Not FDA Approved

Vesugen is an investigational peptide primarily studied in laboratory settings and lacks formal human clinical trial data or FDA approval.

Information compiled from FDA compounding guidance and public regulatory sources. For research and educational purposes only; not medical advice.

Unlock the complete research profile

Create your free CertifiedTide account to access full compound details, mechanisms, safety data, and research tools.